Table 7.

Correlates of attitudes to prescribe anti-obesity drugs: results of multivariate analysis (logistic regression with stepwise variable selection).

Respondents’ characteristics	OR	95%CI	p
Metformin
Setting of practice
Non-University hospital	r.c.	–	–
University hospital	1.48	0.76-2.90	0.25
Public outpatient clinic	0.95	0.52-1.75	0.87
Private outpatient clinic	2.43	1.23-4.81	0.01
Orlistat
Age
≤40	r.c.	–	–
41-60	1.85	1.11-3.08	0.018
>60	4.69	2.53-8.71	<0.0001
Main area of interest
Obesity/nutrition	r.c.	–	–
Thyroid	0.74	0.45-1.24	0.25
Diabetes	1.45	0.73-2.87	0.29
General endocrinology/other	0.33	0.15-0.77	0.01
Management of obesity
Personally/within a dedicated team	r.c.	–	–
Referral to a dietician/nutritionist	0.48	0.30-0.78	0.003
Referral to a 2nd level structure	0.39	0.16-0.95	0.04
Setting of practice
Non-University hospital	r.c.	–	–
University hospital	1.07	0.60-1.90	0.82
Public outpatient clinic	0.57	0.32-1.00	0.05
Private outpatient clinic	0.51	0.29-0.89	0.02
Naltrexone/Bupropion
Main area of interest
Obesity/nutrition	r.c.	–	–
Thyroid	0.5	0.30-0.82	0.007
Diabetes	0.92	0.47-1.80	0.8
General endocrinology/other	0.49	0.22-1.11	0.09
Management of obesity
Personally/within a dedicated team	r.c.	–	–
Referral to a dietician/nutritionist	0.37	0.23-0.61	<0.0001
Referral to a 2nd level structure	0.22	0.07-0.65	0.007
Liraglutide
Main area of interest
Obesity/nutrition	r.c.	–	–
Thyroid	0.52	0.32-0.85	0.01
Diabetes	0.64	0.32-1.24	0.19
General endocrinology/other	0.14	0.07-0.28	<0.0001

r.c. Reference category.